HematologyNews.net

Hematology Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Farmaexplorer.it

Search results for "Quizartinib"

Acute myeloid leukemia ( AML ) remains a highly resistant disease to conventional chemotherapy, with a median survival of only 4 months for relapsed and/or refractory disease. Molecular profiling b ...